fda to reconsider tirzepatide UPDATE [March 7, 2025]: OFA takes case appeals court as legal battle evolves FDA backtracks over Eli Lilly

Hermans et al., 2015)

Previous weight loss drugs relied primarily on stimulating your nervous system or blocking fat absorption, approaches with limited effectiveness and concerning side effects

Although it is not specifically approved for weight loss, it has shown positive results in clinical trials and real-world usage

Drugs do come at a cost. Prime Minister Sir Keir Starmer acknowledged that the government needed to think differently to reduce pressure on the health system and Lilly's CEO, David Ricks, said he welcomed the opportunity to partner with the UK Government on tackling and preventing disease and accelerating innovation to advance care delivery models

Texas is a restricted practice state